학술논문

226th ENMC International Workshop: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20–22 January 2017, Heemskerk, The Netherlands
Document Type
Source
Neuromuscular Disorders. 28(1):77-86
Subject
Biobank
Biomarker
Duchenne muscular dystrophy
Dystrophin
MRI
alanine aminotransferase
aspartate aminotransferase
biological marker
carbonate dehydratase III
corticosteroid
dysferlin
enolase
fukutin related protein
glucocorticoid receptor
glutamate dehydrogenase
immunoglobulin enhancer binding protein
microRNA
microRNA 133a
microRNA 133b
osteopontin
protein enolase 3
stromelysin
unclassified drug
utrophin
vamorolone
alanine aminotransferase level
aspartate aminotransferase blood level
Becker muscular dystrophy
blood analysis
blood sampling
Conference Paper
corticosteroid therapy
CRISPR-CAS9 system
DNA modification
drug design
exon
exon skipping
gene
gene expression
human
lipidomics
LTBP4 gene
Netherlands
nonhuman
nuclear magnetic resonance imaging
priority journal
protein expression
real time polymerase chain reaction
single nucleotide polymorphism
SPP1 gene
urinalysis
urine sampling
workshop
animal
information dissemination
male
metabolism
non profit organization
validation study
Animals
Biomarkers
Humans
Muscular Dystrophy
Duchenne
Organizations
Nonprofit
Validation Studies as Topic
Language
English
ISSN
0960-8966
1873-2364